1. Home
  2. PGEN vs PBPB Comparison

PGEN vs PBPB Comparison

Compare PGEN & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • PBPB
  • Stock Information
  • Founded
  • PGEN 1998
  • PBPB 1977
  • Country
  • PGEN United States
  • PBPB United States
  • Employees
  • PGEN N/A
  • PBPB N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • PBPB Restaurants
  • Sector
  • PGEN Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • PGEN Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • PGEN 292.6M
  • PBPB 305.7M
  • IPO Year
  • PGEN N/A
  • PBPB 2013
  • Fundamental
  • Price
  • PGEN $0.93
  • PBPB $10.40
  • Analyst Decision
  • PGEN Buy
  • PBPB Strong Buy
  • Analyst Count
  • PGEN 5
  • PBPB 3
  • Target Price
  • PGEN $7.00
  • PBPB $15.67
  • AVG Volume (30 Days)
  • PGEN 931.3K
  • PBPB 168.6K
  • Earning Date
  • PGEN 11-14-2024
  • PBPB 11-07-2024
  • Dividend Yield
  • PGEN N/A
  • PBPB N/A
  • EPS Growth
  • PGEN N/A
  • PBPB 641.95
  • EPS
  • PGEN N/A
  • PBPB 1.25
  • Revenue
  • PGEN $3,963,000.00
  • PBPB $471,719,000.00
  • Revenue This Year
  • PGEN N/A
  • PBPB N/A
  • Revenue Next Year
  • PGEN $426.76
  • PBPB $3.71
  • P/E Ratio
  • PGEN N/A
  • PBPB $8.32
  • Revenue Growth
  • PGEN N/A
  • PBPB N/A
  • 52 Week Low
  • PGEN $0.77
  • PBPB $6.28
  • 52 Week High
  • PGEN $1.93
  • PBPB $14.36
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 54.56
  • PBPB 66.70
  • Support Level
  • PGEN $0.84
  • PBPB $9.96
  • Resistance Level
  • PGEN $0.97
  • PBPB $10.39
  • Average True Range (ATR)
  • PGEN 0.07
  • PBPB 0.37
  • MACD
  • PGEN 0.01
  • PBPB 0.01
  • Stochastic Oscillator
  • PGEN 57.89
  • PBPB 61.70

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: